22-49903838-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM4
The ENST00000330817.11(ALG12):āc.1467A>Cā(p.Ter489CysextTer29) variant causes a stop lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,820 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Synonymous variant affecting the same amino acid position (i.e. *489*) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000330817.11 stop_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALG12 | NM_024105.4 | c.1467A>C | p.Ter489CysextTer29 | stop_lost | 10/10 | ENST00000330817.11 | NP_077010.1 | |
ALG12 | XM_017028936.2 | c.1238+341A>C | intron_variant | XP_016884425.1 | ||||
ALG12 | XM_017028937.2 | c.1238+341A>C | intron_variant | XP_016884426.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALG12 | ENST00000330817.11 | c.1467A>C | p.Ter489CysextTer29 | stop_lost | 10/10 | 1 | NM_024105.4 | ENSP00000333813 | P1 | |
ENST00000610245.1 | n.1611T>G | non_coding_transcript_exon_variant | 1/1 | |||||||
ALG12 | ENST00000486602.1 | c.488A>C | p.Glu163Ala | missense_variant | 4/4 | 3 | ENSP00000420630 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461820Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727226
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
ALG12-congenital disorder of glycosylation Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 29, 2022 | This sequence change disrupts the translational stop signal of the ALG12 mRNA. It is expected to extend the length of the ALG12 protein by 29 additional amino acid residues. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ALG12-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at